Radiation exposure for ‘caregivers’ during high-dose outpatient radioiodine therapy
- 1 January 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Radiation Protection Dosimetry
- Vol. 123 (1) , 62-67
- https://doi.org/10.1093/rpd/ncl084
Abstract
On 27 occasions, radiation doses were measured for a family member designated as the ‘caregiver’ for a patient receiving high-dose radioiodine outpatient therapy for differentiated thyroid carcinoma. For 25 of the administrations, patients received 3.7 GBq of 131I. Radiation doses for the designated caregivers were monitored on an hourly basis for 1 week using electronic personal dosemeters. The average penetrating dose was 98 ± 64 μSv. The maximum penetrating dose was 283 μSv. Measured dose rate profiles showed that, on average, one-third of the caregiver dose was received during the journey home from hospital. The mean dose rate profile showed rapid clearance of 131I with three distinct phases. The corresponding clearance half-times were 131I contaminating the home.Keywords
This publication has 3 references indexed in Scilit:
- Biological half-life of iodine in adults with intact thyroid function and in athyreotic persons.Radiation Protection Dosimetry, 2002
- Radiation Exposure From Outpatient Radioactive Iodine (131I) Therapy for Thyroid CarcinomaPublished by American Medical Association (AMA) ,2000
- Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroidEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996